Literature DB >> 15861021

Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes.

Josef Neu1, Christopher M Reverte, Amy D Mackey, Kellym Liboni, Lauren M Tuhacek-Tenace, Marguerite Hatch, Nan Li, Ricardo A Caicedo, Desmond A Schatz, Mark Atkinson.   

Abstract

OBJECTIVE: Type 1 diabetes is an autoimmune disorder that occurs in genetically susceptible individuals. It has been hypothesized that the disease could be triggered by environmental agents that gain entry into the body through small intestinal absorption. Increased intestinal permeability has been reported both in spontaneous animal models of type 1 diabetes and human type 1 diabetes. In these studies, we examined both the physical and functional permeability characteristics of the small intestine in diabetes-prone and control rats.
METHODS: In a series of studies, BioBreeding diabetes-prone(n = 31), BioBreeding diabetes-resistant (n = 20) and control Wistar (n = 25) rats were examined at intervals from 21 to 125 days of age.
RESULTS: The percentage of goblet cells and the mucosal crypt depth were significantly greater in BioBreeding diabetes-prone than BioBreeding diabetes-resistant rats (P < 0.001 and P = 0.01, respectively). BioBreeding diabetes-prone and BioBreeding diabetes-resistant rats expressed less of the tight junction protein claudin (P < 0.05) and exhibited greater intestinal permeability (P < 0.001) than did Wistar rats. Intestinal permeability measured both in vivo and ex vivo decreased in all rat strains as age increased (P < 0.001).
CONCLUSIONS: In a genetically susceptible rodent model of diabetes, early increased intestinal permeability might allow unregulated passage of environmental antigens that could potentially trigger the autoimmune response leading to type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861021     DOI: 10.1097/01.mpg.0000159636.19346.c1

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  56 in total

1.  Enterocytes' tight junctions: From molecules to diseases.

Authors:  Stelios F Assimakopoulos; Ismini Papageorgiou; Aristidis Charonis
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

2.  Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice.

Authors:  Camilla H F Hansen; Christian S Larsen; Henriette O Petersson; Line F Zachariassen; Andreas Vegge; Charlotte Lauridsen; Witold Kot; Łukasz Krych; Dennis S Nielsen; Axel K Hansen
Journal:  Diabetologia       Date:  2019-05-28       Impact factor: 10.122

3.  Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108.

Authors:  R F Schwartz; J Neu; D Schatz; M A Atkinson; C Wasserfall
Journal:  Diabetologia       Date:  2006-11-21       Impact factor: 10.122

Review 4.  Intestinal barrier function: molecular regulation and disease pathogenesis.

Authors:  Katherine R Groschwitz; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

5.  Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.

Authors:  V A Matheus; Lcs Monteiro; R B Oliveira; D A Maschio; C B Collares-Buzato
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-15

6.  Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice.

Authors:  A S Lee; D L Gibson; Y Zhang; H P Sham; B A Vallance; J P Dutz
Journal:  Diabetologia       Date:  2009-12-13       Impact factor: 10.122

7.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

8.  Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat.

Authors:  J T J Visser; K Lammers; A Hoogendijk; M W Boer; S Brugman; S Beijer-Liefers; A Zandvoort; H Harmsen; G Welling; F Stellaard; N A Bos; A Fasano; J Rozing
Journal:  Diabetologia       Date:  2010-09-19       Impact factor: 10.122

9.  An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus.

Authors:  M Simpson; M Mojibian; K Barriga; F W Scott; A Fasano; M Rewers; J M Norris
Journal:  Pediatr Diabetes       Date:  2009-07-20       Impact factor: 4.866

10.  Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes.

Authors:  Majid Mojibian; Habiba Chakir; David E Lefebvre; Jennifer A Crookshank; Brigitte Sonier; Erin Keely; Fraser W Scott
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.